Table 1.
K | K w/covar | |
---|---|---|
M (SE) | M(SE) | |
3 | 2.482 (.065) | 2.482 (.063) |
3+2 | 2.338 (.076) | 2.338 (.076) |
5 | 3.356 (.151) | 3.356 (.152) |
M (SE) | M (SE) | |
3P | 2.410 (.092) | 2.410 (.093) |
3C | 2.554 (.073) | 2.554 (.066) |
3+2P | 2.285 (.127) | 2.285 (.126) |
3+2C | 2.390 (.071) | 2.390 (.072) |
5P | 3.256 (.214) | 3.256 (.217) |
5C | 3.456 (.141) | 3.456 (.141) |
Note. ANOVA and ANCOVA results are reported in main text. 3, 3 + 2, and 5 refer to task conditions (3 targets, 3 targets plus 2 distractors, 5 targets). P and C refer to drug conditions (placebo and cabergoline). The covariate (covar) was z-score normalized Ospan. N = 25